{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:26:46Z","timestamp":1773300406997,"version":"3.50.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008664","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"publisher","award":["3-SRA-2014-314-M-R, 2-SRA-2014-295-Q-R, 1-SRA-2015-114-S-B, 2-SRA-2016-148-Q-R, 2-SRA-2016-311-S-B"],"award-info":[{"award-number":["3-SRA-2014-314-M-R, 2-SRA-2014-295-Q-R, 1-SRA-2015-114-S-B, 2-SRA-2016-148-Q-R, 2-SRA-2016-311-S-B"]}],"id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003092","name":"Diabetes Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["EU-FP7: EE-ASI; BetaCellTherapy; DIABIL-2; H2020: BCellTherapy; IMI2: INNODIA"],"award-info":[{"award-number":["EU-FP7: EE-ASI; BetaCellTherapy; DIABIL-2; H2020: BCellTherapy; IMI2: INNODIA"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00690","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T07:43:20Z","timestamp":1523432600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes"],"prefix":"10.3389","volume":"9","author":[{"given":"Kayleigh M.","family":"van Megen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst-Jan T.","family":"van\u2009\u2019t Wout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart O.","family":"Roep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.2337\/db09-0476","article-title":"Current advances and travails in islet transplantation","volume":"58","author":"Harlan","year":"2009","journal-title":"Diabetes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fimmu.2017.00167","article-title":"Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes","volume":"8","author":"Malmegrim","year":"2017","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jcyt.2015.07.006","article-title":"Predictive factors for prolonged remission after autologous hematopoietic stem cell transplantation in young patients with type 1 diabetes mellitus","volume":"17","author":"Xiang","year":"2015","journal-title":"Cytotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1210\/jc.2015-2776","article-title":"Long-term insulin independence in type 1 diabetes mellitus using a simplified autologous stem cell transplant","volume":"101","author":"Cantu-Rodriguez","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1210\/jc.2011-2188","article-title":"Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves beta-cell function in Chinese patients with new onset of type 1 diabetes","volume":"97","author":"Li","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2337\/dc11-2161","article-title":"Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes","volume":"35","author":"Gu","year":"2012","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/bmt.2015.294","article-title":"Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations","volume":"51","author":"Snarski","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"826","DOI":"10.2337\/dc09-1349","article-title":"Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new-onset type 1 diabetes","volume":"33","author":"Gottlieb","year":"2010","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(11)60895-7","article-title":"Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial","volume":"378","author":"Wherrett","year":"2011","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa1402888","article-title":"Autologous transplantation and maintenance therapy in multiple myeloma","volume":"371","author":"Palumbo","year":"2014","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(16)00739-X","article-title":"Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network","volume":"388","author":"Hermine","year":"2016","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21767\/2575-7725.100011","article-title":"Cure of insulin-dependent diabetes mellitus by an autologous hematopoietic stem cell transplantation performed to control multiple myeloma in a patient with chronic renal failure on regular hemodialysis","volume":"1","author":"Al-Anazi","year":"2017","journal-title":"J Stem Cell Biol Transplant"},{"key":"B13","first-page":"482","article-title":"Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR","volume":"31","author":"Snowden","year":"2004","journal-title":"J Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1352458510383609","article-title":"Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review","volume":"17","author":"Reston","year":"2011","journal-title":"Mult Scler"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"285; author reply","DOI":"10.1001\/jama.298.3.285-a","article-title":"Ethics of hematopoietic stem cell transplantation in type 1 diabetes mellitus","volume":"298","author":"Ross","year":"2007","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.297.14.1599","article-title":"Cellular therapy for type 1 diabetes: has the time come?","volume":"297","author":"Skyler","year":"2007","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"624; author reply 5","DOI":"10.1001\/jama.2009.1099","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"302","author":"Gitelman","year":"2009","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1172\/JCI71691","article-title":"T cell repertoire following autologous stem cell transplantation for multiple sclerosis","volume":"124","author":"Muraro","year":"2014","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1093\/brain\/awt182","article-title":"Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis","volume":"136","author":"Abrahamsson","year":"2013","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"297","author":"Voltarelli","year":"2007","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"301","author":"Couri","year":"2009","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.5966\/sctm.2015-0144","article-title":"Residual beta-cell function predicts clinical response after autologous hematopoietic stem cell transplantation","volume":"5","author":"Xiang","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13287-017-0542-1","article-title":"Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus","volume":"8","author":"Ye","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/pr.2011.57","article-title":"Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases","volume":"71","author":"Daikeler","year":"2012","journal-title":"Pediatr Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jama.299.8.925","article-title":"Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases","volume":"299","author":"Burt","year":"2008","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","article-title":"Haematopoietic stem cell transplantation for autoimmune diseases","volume":"13","author":"Swart","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/03007995.2017.1391079","article-title":"The burden of severe hypoglycemia in type 1 diabetes","volume":"34","author":"Liu","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00125-016-4034-0","article-title":"Risk of death following admission to a UK hospital with diabetic ketoacidosis","volume":"59","author":"Gibb","year":"2016","journal-title":"Diabetologia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMra021678","article-title":"Diabetic retinopathy","volume":"350","author":"Frank","year":"2004","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.294.14.1782","article-title":"Incidence of end-stage renal disease in patients with type 1 diabetes","volume":"294","author":"Finne","year":"2005","journal-title":"JAMA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic Registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jdiacomp.2015.09.002","article-title":"Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes","volume":"29","author":"Niedzwiecki","year":"2015","journal-title":"J Diabetes Complications"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0176860","DOI":"10.1371\/journal.pone.0176860","article-title":"A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes","volume":"12","author":"Marino","year":"2017","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s11892-012-0309-0","article-title":"Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes","volume":"12","author":"Couri","year":"2012","journal-title":"Curr Diab Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1196\/annals.1447.048","article-title":"Autologous hematopoietic stem cell transplantation for type 1 diabetes","volume":"1150","author":"Voltarelli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.2337\/db14-0295","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis","volume":"63","author":"D\u2019Addio","year":"2014","journal-title":"Diabetes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1007\/s00125-017-4403-3","article-title":"Relapsing\/remitting type 1 diabetes","volume":"60","author":"van Megen","year":"2017","journal-title":"Diabetologia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1210\/jc.2012-1206","article-title":"Formation of a human beta-cell population within pancreatic islets is set early in life","volume":"97","author":"Gregg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/adc.75.5.410","article-title":"Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group","volume":"75","author":"Komulainen","year":"1996","journal-title":"Arch Dis Child"},{"key":"B47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11892-015-0694-2","article-title":"Diabetes distress among adolescents with type 1 diabetes: a systematic review","volume":"16","author":"Hagger","year":"2016","journal-title":"Curr Diab Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1542\/peds.2009-0207","article-title":"Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis","volume":"124","author":"Hood","year":"2009","journal-title":"Pediatrics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1399-5448.2010.00720.x","article-title":"Diabetes-specific emotional distress among adolescents: feasibility, reliability, and validity of the problem areas in diabetes-teen version","volume":"12","author":"Weissberg-Benchell","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/dme.12854","article-title":"Academic abilities and glycaemic control in children and young people with type 1 diabetes mellitus","volume":"33","author":"Semenkovich","year":"2016","journal-title":"Diabet Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00690\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T07:43:25Z","timestamp":1523432605000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00690\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2018.00690"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00690","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"article-number":"690"}}